$299.98
27.6410.15%
At close: -
$297.91
-2.07-0.69%
After Hours: Apr 11, 7:59 PM EDT
Comments
Loading...
Strategy Analyst Ratings and Price Targets | NASDAQ:MSTR | Benzinga
Strategy has a consensus price target of $494.93 based on the ratings of 14 analysts. The high is $690 issued by BTIG on December 11, 2023. The low is $140 issued by Jefferies on November 10, 2022. The 3 most-recent analyst ratings were released by Barclays, Keefe, Bruyette & Woods, and Maxim Group on February 10, 2025, February 7, 2025, and February 6, 2025, respectively. With an average price target of $493.67 between Barclays, Keefe, Bruyette & Woods, and Maxim Group, there's an implied 65.71% upside for Strategy from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Keefe, Bruyette & Woods
Maxim Group
Cantor Fitzgerald
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for Strategy
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/10/2025 | Buy Now | 41.32% | Barclays | Ramsey El-Assal64% | $515 → $421 | Maintains | Overweight | Get Alert |
| 02/07/2025 | Buy Now | 87.98% | Keefe, Bruyette & Woods | Bill Papanastasiou61% | → $560 | Initiates | → Outperform | Get Alert |
| 02/06/2025 | Buy Now | 67.84% | Maxim Group | Matthew Galinko37% | $480 → $500 | Maintains | Buy | Get Alert |
| 02/06/2025 | Buy Now | 107.78% | Cantor Fitzgerald | Brett Knoblauch43% | $613 → $619 | Maintains | Overweight | Get Alert |
| 02/06/2025 | Buy Now | 37.29% | Canaccord Genuity | Joseph Vafi66% | $510 → $409 | Maintains | Buy | Get Alert |
| 01/29/2025 | Buy Now | 72.87% | Mizuho | Dan Dolev65% | → $515 | Initiates | → Outperform | Get Alert |
| 01/14/2025 | Buy Now | 118.19% | Benchmark | Mark Palmer75% | $650 → $650 | Reiterates | Buy → Buy | Get Alert |
| 01/06/2025 | Buy Now | 118.19% | Benchmark | Mark Palmer75% | $650 → $650 | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | Buy Now | 101.4% | Bernstein | Gautam Chhugani61% | $60 → $60 | Reiterates | Outperform → Outperform | Get Alert |
| 11/25/2024 | Buy Now | 76.23% | TD Cowen | — | $39.2 → $52.5 | Maintains | Buy | Get Alert |
| 11/25/2024 | Buy Now | 72.87% | Barclays | Ramsey El-Assal64% | $27.5 → $51.5 | Maintains | Overweight | Get Alert |
| 11/25/2024 | Buy Now | 118.19% | Benchmark | Mark Palmer75% | $45 → $65 | Maintains | Buy | Get Alert |
| 11/25/2024 | Buy Now | 101.4% | Bernstein | Gautam Chhugani61% | $29 → $60 | Maintains | Outperform | Get Alert |
| 11/25/2024 | Buy Now | 71.19% | Canaccord Genuity | Joseph Vafi66% | $30 → $51 | Maintains | Buy | Get Alert |
| 11/21/2024 | Buy Now | 91.33% | BTIG | Andrew Harte49% | $29 → $57 | Maintains | Buy | Get Alert |
| 11/19/2024 | Buy Now | 51.05% | Benchmark | Mark Palmer75% | $30 → $45 | Maintains | Buy | Get Alert |
| 11/04/2024 | Buy Now | -7.69% | Barclays | Ramsey El-Assal64% | $22.5 → $27.5 | Maintains | Overweight | Get Alert |
| 10/31/2024 | Buy Now | 0.7% | Canaccord Genuity | Joseph Vafi66% | $17.3 → $30 | Maintains | Buy | Get Alert |
| 10/31/2024 | Buy Now | -9.37% | Maxim Group | Matthew Galinko37% | $19.3 → $27 | Maintains | Buy | Get Alert |
| 10/31/2024 | Buy Now | 0.7% | TD Cowen | Lance Vitanza74% | $20 → $30 | Maintains | Buy | Get Alert |
| 10/31/2024 | Buy Now | 0.7% | Benchmark | Mark Palmer75% | $24.5 → $30 | Maintains | Buy | Get Alert |
| 10/21/2024 | Buy Now | -19.44% | BTIG | Andrew Harte49% | $18 → $24 | Maintains | Buy | Get Alert |
| 10/18/2024 | Buy Now | -17.76% | Benchmark | Mark Palmer75% | $21.5 → $24.5 | Maintains | Buy | Get Alert |
| 10/14/2024 | Buy Now | -24.47% | Barclays | Ramsey El-Assal64% | $17.3 → $22.5 | Maintains | Overweight | Get Alert |
| 10/09/2024 | Buy Now | -2.66% | Bernstein | Gautam Chhugani61% | $289 → $29 | Maintains | Outperform | Get Alert |
| 09/23/2024 | Buy Now | -41.93% | Barclays | Ramsey El-Assal64% | $14.6 → $17.3 | Maintains | Overweight | Get Alert |
| 09/23/2024 | Buy Now | -32.87% | TD Cowen | Lance Vitanza74% | $19.5 → $20 | Maintains | Buy | Get Alert |
| 09/16/2024 | Buy Now | -41.93% | Canaccord Genuity | Joseph Vafi66% | $18.5 → $17.3 | Maintains | Buy | Get Alert |
| 09/06/2024 | Buy Now | -50.99% | Barclays | Ramsey El-Assal64% | → $14.6 | Initiates | → Overweight | Get Alert |
| 08/21/2024 | Buy Now | -34.88% | Cantor Fitzgerald | Brett Knoblauch43% | → $19.4 | Initiates | → Overweight | Get Alert |
| 08/02/2024 | Buy Now | 547.85% | Maxim Group | Matthew Galinko37% | $18.35 → $19.3 | Maintains | Buy | Get Alert |
| 08/02/2024 | Buy Now | 621.69% | Benchmark | Mark Palmer75% | $18.75 → $21.5 | Maintains | Buy | Get Alert |
| 06/25/2024 | Buy Now | 515.96% | Maxim Group | Matthew Galinko37% | → $18.35 | Initiates | → Buy | Get Alert |
| 06/24/2024 | Buy Now | 512.94% | Canaccord Genuity | Joseph Vafi66% | $20.47 → $18.26 | Maintains | Buy | Get Alert |
| 06/21/2024 | Buy Now | 531.06% | TD Cowen | Lance Vitanza74% | $14.5 → $18.8 | Maintains | Buy | Get Alert |
| 06/14/2024 | Buy Now | 870.09% | Bernstein | Gautam Chhugani61% | → $28.9 | Initiates | → Outperform | Get Alert |
| 06/13/2024 | Buy Now | 870.09% | Bernstein | Gautam Chhugani61% | → $28.9 | Initiates | → Outperform | Get Alert |
| 05/29/2024 | Buy Now | 587.12% | Canaccord Genuity | Joseph Vafi66% | $15.9 → $20.47 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | 529.38% | Benchmark | Mark Palmer75% | $18.75 → $18.75 | Reiterates | Buy → Buy | Get Alert |
| 04/30/2024 | Buy Now | 433.72% | Canaccord Genuity | Joseph Vafi66% | $18.1 → $15.9 | Maintains | Buy | Get Alert |
| 04/25/2024 | Buy Now | 529.38% | Benchmark | Mark Palmer75% | $18.75 → $18.75 | Reiterates | Buy → Buy | Get Alert |
| 04/08/2024 | Buy Now | 529.38% | Benchmark | Mark Palmer75% | $9.9 → $18.75 | Maintains | Buy | Get Alert |
| 04/05/2024 | Buy Now | 504.21% | BTIG | Andrew Harte49% | $7.8 → $18 | Maintains | Buy | Get Alert |
| 03/28/2024 | Buy Now | 507.57% | Canaccord Genuity | Joseph Vafi66% | → $18.1 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2024 | Buy Now | 386.72% | TD Cowen | Lance Vitanza74% | $15.6 → $14.5 | Maintains | Outperform | Get Alert |
| 03/12/2024 | Buy Now | 423.65% | TD Cowen | Lance Vitanza74% | $12.2 → $15.6 | Maintains | Outperform | Get Alert |
| 03/12/2024 | Buy Now | 507.57% | Canaccord Genuity | Joseph Vafi66% | $9.75 → $18.1 | Maintains | Buy | Get Alert |
| 12/28/2023 | Buy Now | 165.52% | Canaccord Genuity | Joseph Vafi66% | $6.7 → $7.91 | Maintains | Buy | Get Alert |
| 12/11/2023 | Buy Now | 131.61% | BTIG | Mark Palmer75% | $5.6 → $6.9 | Maintains | Buy | Get Alert |
| 12/06/2023 | Buy Now | 124.9% | Canaccord Genuity | Joseph Vafi66% | $5.54 → $6.7 | Maintains | Buy | Get Alert |
| 12/05/2023 | Buy Now | 124.9% | Canaccord Genuity | Joseph Vafi66% | $5.54 → $6.7 | Maintains | Buy | Get Alert |
| 11/02/2023 | Buy Now | 85.96% | Canaccord Genuity | Joseph Vafi66% | $5.13 → $5.54 | Maintains | Buy | Get Alert |
| 07/26/2023 | Buy Now | 74.55% | TD Cowen | Lance Vitanza74% | → $5.2 | Initiates | → Outperform | Get Alert |
| 07/11/2023 | Buy Now | 64.48% | BTIG | Mark Palmer75% | → $4.9 | Assumes | → Buy | Get Alert |
| 04/28/2023 | Buy Now | 44.34% | Berenberg | Mark Palmer75% | → $4.3 | Initiates | → Buy | Get Alert |
| 02/03/2023 | Buy Now | 34.27% | Canaccord Genuity | Joseph Vafi66% | $3.72 → $4 | Maintains | Buy | Get Alert |
| 11/10/2022 | Buy Now | -53.01% | Jefferies | Brent Thill74% | $1.75 → $1.4 | Maintains | Underperform | Get Alert |
| 10/31/2022 | Buy Now | -41.26% | Jefferies | Brent Thill74% | $1.8 → $1.75 | Maintains | Underperform | Get Alert |
| 07/26/2022 | Buy Now | -39.58% | Jefferies | Brent Thill74% | → $1.8 | Downgrade | Hold → Underperform | Get Alert |
| 05/23/2022 | Buy Now | -27.83% | Jefferies | Brent Thill74% | $2.25 → $2.15 | Maintains | Hold | Get Alert |
FAQ
What is the target price for Strategy (MSTR) stock?
The latest price target for Strategy (NASDAQ:MSTR) was reported by Barclays on February 10, 2025. The analyst firm set a price target for $421.00 expecting MSTR to rise to within 12 months (a possible 41.32% upside). 41 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Strategy (MSTR)?
The latest analyst rating for Strategy (NASDAQ:MSTR) was provided by Barclays, and Strategy maintained their overweight rating.
When was the last upgrade for Strategy (MSTR)?
There is no last upgrade for Strategy
When was the last downgrade for Strategy (MSTR)?
The last downgrade for Strategy happened on July 26, 2022 when Jefferies changed their price target from N/A to $180 for Strategy.
When is the next analyst rating going to be posted or updated for Strategy (MSTR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Strategy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Strategy was filed on February 10, 2025 so you should expect the next rating to be made available sometime around February 10, 2026.
Is the Analyst Rating Strategy (MSTR) correct?
While ratings are subjective and will change, the latest Strategy (MSTR) rating was a maintained with a price target of $515.00 to $421.00. The current price Strategy (MSTR) is trading at is $297.91, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.